Investment Summary

SHS Capital Invests In Develco Pharma

On December 17, 2020, private equity firm SHS Capital invested in life science company Develco Pharma

Investment Highlights
  • This is SHS Capital’s 8th transaction in the Life Science sector.
  • This is SHS Capital’s 6th transaction in Switzerland.

Investment Summary

Date 2020-12-17
Target Develco Pharma
Sector Life Science
Investor(s) SHS Capital
Deal Type Growth Capital

Target

Develco Pharma

Pratteln, Switzerland
Develco Pharma operates in Switzerland and Schopfheim, Germany, developing and manufacturing orally administered medicines containing known active ingredients in formulations that offer delayed or modified release of active ingredients. Develco has state-of-the-art production operations of its own; its customers include world-leading pharmaceuticals companies that market the products internationally. Develco Pharma was founded in 2006 and is based in Pratteln, Switzerland.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor
DESCRIPTION

SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.


DEAL STATS #
Overall 28 of 35
Sector: Life Science M&A 8 of 9
Type: Growth Capital M&A Deals 17 of 21
Country: Switzerland M&A 6 of 7
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-16 Single Use Support

Kufstein, Austria

Single Use Support is a process solution provider specializing in fluid and cold chain management of drug substances. The company focuses on developing solutions to provide manufacturers with 100% safe and efficient handling, liquid transfer, freezing, and cold chain shipping of advanced therapies and biologics in pharmaceutical production. Single Use Support Gmbh was founded in 2016 and is based in Kufstein, Germany.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-12 Blue Ocean Spine

Tuttlingen, Germany

Blue Ocean Spine develops and markets innovative, functional spinal implants to support minimally invasive fusion techniques in spine surgery. The company uses additive manufacturing technology to combine better functionality and product differentiation with cost efficiency. Blue Ocean Spine was founded in 2020 and is based in Tuttlingen, Germany.

Buy -